Jaguar Health Eulerpool News

Jaguar Health Aktie News

Jaguar Health wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Jaguar Health News stellen wir hier zusammen.

• 17. Juni ·

  Yahoo
  Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
• 17. Juni ·

  Yahoo
  Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
• 11. Juni ·

  Yahoo
  First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
• 6. Juni ·

  Yahoo
  Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series
• 21. Mai ·

  Yahoo
  Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
• 14. Mai ·

  Yahoo
  Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
• 7. Mai ·

  Yahoo
  Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
• 28. April ·

  Yahoo
  Jaguar Health to Present Initial Results from the Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) During an April 30 Investor Webcast
• 15. April ·

  Yahoo
  Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
• 8. April ·

  Yahoo
  Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product